High-Risk Prostate Cancer Linked to Higher Recurrence…

High-Risk Prostate Cancer Linked to Higher Recurrence Rates, Lower Survival, and Greater Healthcare Costs TALMedora Health Desk A large real-world study from the United States has found that men diagnosed with high-risk localized prostate cancer continue to face significantly greater health challenges even after undergoing radical prostatectomy, one of the most common curative treatments for the disease. Researchers reported that patients with high-risk prostate cancer experienced more cancer recurrences, higher rates of disease spread, lower long-term survival, and substantially greater healthcare costs compared with men who had lower-risk disease. The findings highlight the need for closer monitoring and more personalized treatment strategies for patients diagnosed with aggressive prostate cancer. Localized prostate cancer refers to cancer that remains confined to the prostate gland and has not spread to distant organs. Doctors classify these cancers into different risk groups using factors such as: • PSA (Prostate-Specific Antigen) levels • Gleason score • Tumor stage Patients with high-risk disease typically have higher PSA levels, more aggressive tumor characteristics, or more advanced local disease at diagnosis. Although surgery can remove the prostate gland, some patients remain at increased risk for recurrence and future metastasis. The study analyzed nearly 19,000 men who underwent radical prostatectomy between 2016 a